Industrial Microbiology Market (Product: Equipment and Systems, Reaction Consumables, Laboratory Supplies, Test Insights; End-Use: Food and Beverages, Pharmaceutical Biotechnology, Agricultural, Environmental, Cosmetic and Personal Care, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Industrial Microbiology Market 

5.1. COVID-19 Landscape: Industrial Microbiology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Industrial Microbiology Market, By Product

8.1. Industrial Microbiology Market, by Product, 2024-2033

8.1.1 Equipment and Systems

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Reaction Consumables

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Laboratory Supplies

8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Industrial Microbiology Market, By Test

9.1. Industrial Microbiology Market, by Test, 2024-2033

9.1.1. Sterility Testing

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Microbial Limits Testing

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Bio-burden Testing

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Water and Environmental Testing

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Industrial Microbiology Market, By End-Use 

10.1. Industrial Microbiology Market, by End-Use, 2024-2033

10.1.1. Food and Beverages

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Pharmaceutical Biotechnology

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Agricultural

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Environmental

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Cosmetic and Personal Care

10.1.5.1. Market Revenue and Forecast (2021-2033)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Industrial Microbiology Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2021-2033)

11.1.2. Market Revenue and Forecast, by Test (2021-2033)

11.1.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Test (2021-2033)

11.1.4.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Test (2021-2033)

11.1.5.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2021-2033)

11.2.2. Market Revenue and Forecast, by Test (2021-2033)

11.2.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Test (2021-2033)

11.2.4.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Test (2021-2033)

11.2.5.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Test (2021-2033)

11.2.6.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Test (2021-2033)

11.2.7.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2021-2033)

11.3.2. Market Revenue and Forecast, by Test (2021-2033)

11.3.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Test (2021-2033)

11.3.4.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Test (2021-2033)

11.3.5.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Test (2021-2033)

11.3.6.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Test (2021-2033)

11.3.7.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2021-2033)

11.4.2. Market Revenue and Forecast, by Test (2021-2033)

11.4.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Test (2021-2033)

11.4.4.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Test (2021-2033)

11.4.5.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Test (2021-2033)

11.4.6.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Test (2021-2033)

11.4.7.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2021-2033)

11.5.2. Market Revenue and Forecast, by Test (2021-2033)

11.5.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Test (2021-2033)

11.5.4.3. Market Revenue and Forecast, by End-Use (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Test (2021-2033)

11.5.5.3. Market Revenue and Forecast, by End-Use (2021-2033)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Danaher Corporation

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Bio-Rad Laboratories, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Merck KGaA

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Becton, Dickinson and Company

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Asiagel Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Eppendorf AG

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. bioMérieux SA

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Novamed

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. QIAGEN

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample